glp-1 microdosing Microdose Protocol People Are Microdosing Weight-Loss Drugs

The FDA allows bulk compounding of prescription medications, which are in shortage, and many Americans are now taking compounded GLP-1 medications

Common side effects reported in clinical literature include: Nausea (often most pronounced during dose escalation) Vomiting Diarrhea or constipation Injection site reactions (for injectable forms) Headache Fatigue More serious considerations (discuss with your provider): GLP-1 medications carry boxed warnings regarding thyroid C-cell tumors

Yu RJ, Krantz MS, Phillips EJ, Stone CA

As early services in Europe and Australia are already demonstrating, the next evolution isn't simply expanding access to medication

In clinical trials, cagrilintide alone improved glycemic parameters modestly

3 Reduced Liver Fat GLP-1 activity is associated with decreased fat deposition and inflammation in the liver, which may help treat fatty liver disease